Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT00899626
- Status
- Recruiting
Conditions
- Colorectal Cancer
- Esophageal Cancer
- Gastric Cancer
- Pancreatic Cancer
- Precancerous Condition
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.
Key Dates
- Start date
- Jun 30, 2002
- Status verified
- Mar 2026
- Primary completion
- Oct 31, 2045
- Completion
- Oct 31, 2045
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Identification of new potential biomarkers of increased gastrointestinal cancer risk using tissue and biofluid samples from patients undergoing colonoscopy, endoscopy, or surgery [ Time Frame: Through study completion, approximately 30 years ]
Central Contacts
- Kristen K Ciombor, MD6159368422
- Keeli B Lewis, BS
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | Clinical Trials Office - Vanderbilt-Ingram Cancer Center 800-811-8480 |
| Veterans Affairs Medical Center - Nashville | Nashville | Tennessee | 37212 | Clinical Trials Office - Veterans Affairs Medical Center - Nas 615-327-4751 |
Find similar trials in Nashville, TN
By specialty
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- Familial Investigations of Childhood Cancer PredispositionRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California